1 completed, 1 terminated. 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Noah Merin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure Multiple Doses of Anti-SARS-CoV-2 convalescent plasma - Covid-19, Sars-CoV2 | Early Phase 1 | Terminated | Noah Merin | 6 | 2020-06-27 | 2021-11-08 |
| Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL Total Body Irradiation, Haploidentical Stem Cell Transplantation, CD56-Enriched Donor Lymphocyte Infusion - Multiple Myeloma, CLL | Phase 1 | Completed | Noah Merin | 20 | 2018-07-18 | 2024-11-12 |
COVID-19 (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Multiple Myeloma (1) · Neoplasm, Residual (1)
Bendamustine Hydrochloride (1) · COVID-19 Serotherapy (1) · Rituximab (1) · Whole-Body Irradiation (1) · fludarabine (1) · fludarabine phosphate (1)
United States (2)